Denmark: Novo Holdings acquires BBI from Exponent for £400m-plus

Novo Holdings, the Copenhagen-based global life sciences investor, has acquired BBI Group, a supplier of products and services to the diagnostics and life sciences industries, from UK private equity firm Exponent for an enterprise value of over £400m (US$563.6m). Novo Holdings becomes the majority shareholder of the company. Founded in 1986, BBI provides critical reagents…

You must be a HMI Subscriber to view this content.

Subscribe Now »